Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26267223 | 0.90 | ALDH1A1 (0.39) | ALDH1A1TSHRDNM1 | |
| SCHEMBL25777500 | 0.90 | ALDH1A1 (0.39) | ALDH1A1TSHRDNM1 | |
| SCHEMBL26243208 | 0.90 | DNM1 (0.44) | ALDH1A1TSHRDNM1CYP1A2CYP2D6 | |
| SCHEMBL26239799 | 0.88 | ALDH1A1 (0.38) | ALDH1A1TSHRDNM1HTR2AHRH1 | |
| SCHEMBL13397468 | 0.87 | ALDH1A1 (0.41) | ALDH1A1TSHRDNM1HTR2AHRH1 | |
| SCHEMBL26350756 | 0.84 | ALDH1A1 (0.35) | ALDH1A1TSHRDNM1 | |
| SCHEMBL23791944 | 0.83 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1HTR2AHRH1 | |
| SCHEMBL26355365 | 0.82 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL10289401 | 0.81 | CA12 (0.44) | ALDH1A1TSHRDNM1TDP1CA12 | |
| SCHEMBL571029 | 0.78 | ALDH1A1 (0.43) | ALDH1A1TSHRDNM1TDP1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3259293-B1 | TEMPERATURE-RESISTANT ISOCYANATE-BASED FOAMS HAVING A HIGH FLAME RESISTANCE | BASF SE (DE) | 2021-08-04 | — | — | EP | claimed |
| EP-2930219-A1 | Reactive adhesive systems and their use | Jowat AG (DE) | 2015-10-14 | — | — | EP | claimed |
| US-20230285310-A1 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | ARES CAPITAL CORPORATION, AS AGENT | 2023-09-14 | — | — | US | disclosed |
| US-20230285310-A1 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | ARES CAPITAL CORPORATION, AS AGENT | 2023-09-14 | — | — | US | disclosed |
| WO-2023154818-A1 | MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS | MODERNATX, INC. (US) | 2023-08-17 | — | — | WO | disclosed |
| US-10626223-B2 | Polyurethane-organopolysiloxanes | RUDOLF GMBH (DE) | 2020-04-21 | — | — | US | disclosed |
| EP-2930219-B1 | Reactive adhesive systems and their use | JOWAT AG (DE) | 2018-12-26 | — | — | EP | disclosed |
| US-20180155503-A1 | POLYURETHANE-ORGANOPOLYSILOXANES | RUDOLF GMBH (DE) | 2018-06-07 | — | — | US | disclosed |
| US-9642804-B2 | Cationic lipids with various head groups for oligonucleotide delivery | SIRNA THERAPEUTICS, INC. (US) | 2017-05-09 | — | — | US | disclosed |
| US-9642804-B2 | Cationic lipids with various head groups for oligonucleotide delivery | SIRNA THERAPEUTICS, INC. (US) | 2017-05-09 | — | — | US | disclosed |
| US-20160113874-A1 | NOVEL CATATONIC LIPIDS WITH VARIOUS HEAD GROUPS FOR OLIGONUCLEOTIDE DELIVERY | BANK OF AMERICA, N.A. | 2016-04-28 | — | — | US | disclosed |
| US-9181295-B2 | Cationic lipids with various head groups for oligonucleotide delivery | SIRNA THERAPEUTICS, INC. (US) | 2015-11-10 | — | — | US | disclosed |
| EP-2930219-A1 | Reactive adhesive systems and their use | Jowat AG (DE) | 2015-10-14 | — | — | EP | disclosed |
| US-20120322721-A1 | DRY GROWTH HORMONE COMPOSITION TRANSIENTLY LINKED TO A POLYMER CARRIER | ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (DK) | 2012-12-20 | — | — | US | disclosed |
| US-20120253032-A1 | NOVEL CATIONIC LIPIDS WITH SHORT LIPID CHAINS FOR OLIGONUCLEOTIDE DELIVERY | MERCK SHARP & DOHME CORPORATION | 2012-10-04 | — | — | US | disclosed |
| US-20120149894-A1 | NOVEL CATIONIC LIPIDS WITH VARIOUS HEAD GROUPS FOR OLIGONUCLEOTIDE DELIVERY | BANK OF AMERICA, N.A. | 2012-06-14 | — | — | US | disclosed |
| US-20120149894-A1 | NOVEL CATIONIC LIPIDS WITH VARIOUS HEAD GROUPS FOR OLIGONUCLEOTIDE DELIVERY | BANK OF AMERICA, N.A. | 2012-06-14 | — | — | US | disclosed |
| US-8119654-B2 | Indenoisoquinolinone analogs and methods of use thereof | INOTEK PHARMACEUTICALS CORPORATION (US) | 2012-02-21 | — | — | US | disclosed |
| US-5693686-A | RIGID, LOW-DENSITY POLYURETHANE FOAMS USING AN ACIDIC POLYISOCYANATE MONOMER TO STABILIZE THE BLOWING AGENTS | BAYER CORPORATION (US) | 1997-12-02 | — | — | US | disclosed |
| US-5464560-A | Polyurethanes | BAYER CORPORATION (US) | 1995-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160113874-A1 | NOVEL CATATONIC LIPIDS WITH VARIOUS HEAD GROUPS FOR OLIGONUCLEOTIDE DELIVERY | NPC1L1, NPC1, ABCB4 | ALDH1A1 4279/4885TSHR 1921/4885DNM1 266/4885 |
| US-20120322721-A1 | DRY GROWTH HORMONE COMPOSITION TRANSIENTLY LINKED TO A POLYMER CARRIER | GHRHR, GHSR, GCG | ALDH1A1 4509/4885TSHR 132/4885DNM1 4847/4885 |
| US-20120253032-A1 | NOVEL CATIONIC LIPIDS WITH SHORT LIPID CHAINS FOR OLIGONUCLEOTIDE DELIVERY | NPC1L1, LDLR, NPC1 | ALDH1A1 4810/4885TSHR 2290/4885DNM1 476/4885 |
| US-20230285310-A1 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | CFTR, TSLP, MTREX | ALDH1A1 3126/4885TSHR 2383/4885DNM1 704/4885 |
| US-20120149894-A1 | NOVEL CATIONIC LIPIDS WITH VARIOUS HEAD GROUPS FOR OLIGONUCLEOTIDE DELIVERY | NPC1L1, NPC1, LDLR | ALDH1A1 4850/4885TSHR 1615/4885DNM1 668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.